Cognitive Behavioral Therapy for Insomnia in Heart Disease Patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates the effectiveness of Cognitive Behavioral Therapy for Insomnia (CBT-I) in patients with coronary heart disease (CHD), who often experience insomnia. The study will involve a randomized intervention with 66 outpatient participants diagnosed with insomnia, aiming to document the therapy's impact on sleep quality and cardiovascular health. Additionally, it will explore the biological and psychological mechanisms behind the therapy's effects and include a health-economic simulation and qualitative assessments of participant experiences.

Why it matters

Who can join: the full rules

Inclusion criteria (all the following):

* Aged 18-75 years and signed informed consent and expected cooperation according to ICH/GCP and national/local regulations
* Hospitalised with acute myocardial infarction and/or angiography-verified coronary atherosclerosis, or a coronary revascularisation procedure at Drammen Hospital 2021-2024
* A positive score for insomnia measured with Bergen Insomnia Score
* At least 10 of 14 daily diaries completed of the sleep diary during pre-randomization assessment

Exclusion criteria (any of the following):

* Any condition or situation, that in the investigator's opinion could put the subject at significant risk, confound the study results, interfere significantly with the subject participation in the study, or rendering informed consent unfeasible not limited to:
* Moderate or severe cognitive impairment (i.e. recorded in hospital records or a Montreal Cognitive Assessment brief version score \< 11), seizure disorders, active suicidal intent or plans, substance or alcohol dependence, psychotic disease, major depressive disorders or bipolar disorders, receiving concurrent psychological treatments, and ongoing night shift work.
* Neurological or musculoskeletal disorders that restrict movement of the dominant arm because of the possible confounding effects on wrist actigraphy recordings.
* A diagnosis of heart failure recorded in the hospital medical records and/or an NT-proBNP \>125 pg/mL
* Short life expectancy (\<12 months) due to end-organ (i.e COPD 4, CKD 4/5) or malignant diseases
* Not being able to understand Norwegian.
* No other significant sleep disorder, as assessed via the Structured Clinical Interview for Sleep disorders (Kallestad et al., 2022)
* A clinical diagnosis of Obstructive Sleep Apnea (OSA) (not treated with CPAP) recorded in the hospital medical records, under evaluation for OSA, and/or a score ≥5 on the STOP-Bang OSA screening questionnaire

Where it's running

• Vestre Viken Trust Drammen hospital
  Drammen, Buskerud, Norway Recruiting

Study contacts

• Study coordinator: John D Munkhaugen, MD, PhD
• Email: johmun@vestreviken.no
• Phone: +4797524194

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

• Prospective cardiac surgery cohort to improve perioperative care

  A multi-center study will test a large, forward-looking database of adults undergoing heart surgery to better understand what affects short- and long-term outcomes.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07662317

• Mazdutide and coronary plaque in people with coronary artery disease and overweight or obesity

  This study tests whether mazdutide can slow or reduce coronary plaque build-up in adults with coronary artery disease who are overweight or obese.

  Recruiting Phase 4 China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07657676

• Understanding risk factors for cognitive problems in people with coronary heart disease

  In people with coronary heart disease, this study tests how metabolic factors and imaging features relate to cognitive impairment.

  Recruiting Beijing Anzhen Hospital · Beijing, China · NCT07657624

• Yiyang Huoluo Decoction for coronary heart disease with atherosclerosis in older adults

  This study will test whether adding the Yiyang Huoluo herbal decoction to standard heart care helps people aged 50–75 with coronary heart disease and atherosclerosis.

  Recruiting Phase 1/2 Hangzhou City University · Huzhou, Zhejiang · NCT07493603

• Glycocalyx and oxidative stress in blood vessel lining during coronary bypass surgery

  This project will see if changes in the endothelial glycocalyx and oxidative stress markers relate to microvascular function and outcomes in adults having elective coronary artery bypass grafting.

  Recruiting Josip Juraj Strossmayer University of Osijek · Osijek · NCT07451873

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.